Oral and dental adverse drug reactions

Periodontology 2000

Volumn 46, Issue 1, 2008, Pages 9-26

  Seymour, Robin A ^a   Rudralingham, Meenakshi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; DRUG THERAPY; HUMAN; MOUTH DISEASE; PERIODONTAL DISEASE; SALIVARY GLAND DISEASE; TOOTH DISEASE;

DRUG ERUPTIONS; DRUG THERAPY; HUMANS; MOUTH DISEASES; PERIODONTAL DISEASES; SALIVARY GLAND DISEASES; TOOTH DISEASES;

EID: 38149133631     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2008.00226.x     Document Type: Article

References (95)

1. Aberer W, Holub H, Strohal R, Slavicek R. Palladium in dental alloys - the dermatologists' responsibility to warn? Contact Dermatitis 1993 : 28 : 163 165.
2. Addy M, Moran J, Davies RM, Beak A, Lewis A. The effect of single morning and evening rinses of chlorhexidine on the development of tooth staining and plaque accumulation. A blind cross-over trial. J Clin Periodontol 1982 : 9 : 134 140.
3. Addy M, Moran J, Newcombe R, Warren P. The comparative tea staining potential of phenolic, chlorhexidine and anti-adhesive mouthrinses. J Clin Periodontol 1995 : 22 : 923 928.
4. Addy M, Prayitno S, Taylor L, Cadogan S. An in vitro study of the role of dietary factors in the aetiology of tooth staining associated with the use of chlorhexidine. J Periodontal Res 1979 : 14 : 403 410.
5. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005 : 23 : 8580 8587.
6. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 2001 : 46 : 413 423.
7. Beehner ME, Houston GD, Young JD. Oral pigmentation secondary to minocycline therapy. J Oral Maxillofac Surg 1986 : 44 : 582 584.
8. Boulinguez S, Reix S, Bedane C, Debrock C, Bouyssou-Gauthier ML, Sparsa A, Le Brun V, De Vencay P, Bernard P, Bonnetblanc JM. Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol 2000 : 143 : 1261 1265.
9. Brannstrom M, Lindskog S, Nordenvall KJ. Enamel hypoplasia in permanent teeth induced by periodontal ligament anesthesia of primary teeth. J Am Dent Assoc 1984 : 109 : 735 736.
10. Brannstrom M, Nordenvall KJ, Hedstrom KG. Periodontal tissue changes after intraligamentary anesthesia. ASDC J Dent Child 1982 : 49 : 417 423.
11. Cameron AJ, Baron JH, Priestley BL. Erythema multiforme, drugs, and ulcerative colitis. Br Med J 1966 : 12 : 1174 1178.
12. Caplan GA, Brigham BA. Marijuana smoking and carcinoma of the tongue. Is there an association Cancer 1990 : 66 : 1005 1006.
13. Carpenter GH, Pramanik R, Proctor GB. An in vitro model of chlorhexidine-induced tooth staining. J Periodontal Res 2005 : 40 : 225 230.
14. Catellani JE, Harvey S, Erickson SH, Cherkin D. Effect of oral contraceptive cycle on dry socket (localized alveolar osteitis). J Am Dent Assoc 1980 : 101 : 777 780.
15. Chu P, Van SL, Yen TS, Berger TG. Minocycline hyperpigmentation localized to the lips: an unusual fixed drug reaction? J Am Acad Dermatol 1994 : 30 : 802 803.
16. Dello Russo NM, Temple HV. Cocaine effects on gingiva. J Am Dent Assoc 1982 : 104 : 13.
17. Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. Br Med J 1998 : 317 : 839 843.
18. Dunlap CL, Vincent SK, Barker BF. Allergic reaction to orthodontic wire: report of case. J Am Dent Assoc 1989 : 118 : 449 450.
19. Ellingsen JE, Rolla G, Eriksen HM. Extrinsic dental stain caused by chlorhexidine and other denaturing agents. J Clin Periodontol 1982 : 9 : 317 322.
20. Eriksen HM, Solheim H, Nordbo H. Chemical plaque control and prevention of extrinsic tooth discoloration in vivo. Acta Odontol Scand 1983 : 41 : 87 91.
21. Feaver F. Action called for on sale of toothache solutions. Br Dent J 1982 : 152 : 3.
22. Fricain JC, Sibaud V, Campana F, Lepreux S, Taieb A. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology 2005 : 210 : 229 232.
23. Garcia AG, Grana PM, Sampedro FG, Diago MP, Rey JM. Does oral contraceptive use affect the incidence of complications after extraction of a mandibular third molar? Br Dent J 2003 : 194 : 453 455.
24. Giansanti JS, Tillery DE, Olansky S. Oral mucosal pigmentation resulting from antimalarial therapy. Oral Surg Oral Med Oral Pathol 1971 : 31 : 66 69.
25. Girgis SS, Staple PH, Miller WA, Sedransk N, Thompson T. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy. J Periodontol 1980 : 51 : 474 482.
26. Gotrick B, Akerman S, Ericson D, Torstenson R, Tobin G. Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res 2004 : 83 : 393 397.
27. Greco S, Mazzaglia G, Caputi AP, Pagliaro L. Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. Ann Pharmacother 1997 : 31 : 1548.
28. Hammarstrom L. Specific uptake of some drugs in ameloblasts and developing enamel. Acta Odontol Scand 1970 : 28 : 187 195.
29. Hanson JW, Myrianthopoulos NC, Harvey MA, Smith DW. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976 : 89 : 662 668.
30. Harris M, Goldhaber P. Root abnormalities in epileptics and the inhibition of parathyroid hormone induced bone resorption by diphenyl hydantoin in tissue culture. Arch Oral Biol 1974 : 19 : 981 984.
31. Harrison RD, Becker BA. Relation of dosage and time of administration of diphenylhydantoin to its teratogenic effects in mice. Teratology 1969 : 2 : 305.
32. Hassell JR, Greenberg JH, Johnston MC. Inhibition of cranial neural crest cell development by vitamin A in the cultured chick embryo. J Embryol Exp Morphol 1977 : 39 : 267 271.
33. Heikkinen T, Alvesalo L, Osborne RH, Pirttiniemi P. Maternal smoking and tooth formation in the foetus. I. Tooth crown size in the deciduous dentition. Early Hum Dev 1992 : 30 : 49 59.
34. Herlofson BB, Brodin P, Aars H. Increased human gingival blood flow induced by sodium lauryl sulfate. J Clin Periodontol 1996 : 23 : 1004 1007.
35. Hertz RS, Beckstead PC, Brown WJ. Epithelial melanosis of the gingiva possibly resulting from the use of oral contraceptives. J Am Dent Assoc 1980 : 100 : 713 714.
36. Hobson P. Sugar based medicines and dental disease. Community Dent Health 1985 : 2 : 57 62.
37. Hurd RW, Wilder BJ, Van Rinsvelt HA. Valproate, birth defects, and zinc. Lancet 1983 : 1 : 181.
38. Ibbotson SH, Speight EL, Macleod RI, Smart ER, Lawrence CM. The relevance and effect of amalgam replacement in subjects with oral lichenoid reactions. Br J Dermatol 1996 : 134 : 420 423.
39. Imbur DJ, Bourne RB. Iodide mumps following excretory urography. J Urol 1972 : 108 : 629 630.
40. James J, Ferguson MM, Forsyth A. Mercury allergy as a cause of burning mouth. Br Dent J 1985 : 159 : 392.
41. Janket SJ, Jones JA, Rich S, Meurman J, Garcia R, Miller D. Xerostomic medications and oral health: the Veterans Dental Study (part I). Gerodontology 2003 : 20 : 41 49.
42. Kahl KG, Hagenah J, Zapf S, Trillenberg P, Klein C, Lencer R. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology (Berlin) 2004 : 173 : 229 230.
43. Katz H. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases. J Endod 2005 : 31 : 831 834.
44. Kawaguchi M, Yamagishi H. Receptive systems for drugs in salivary gland cells. Nippon Yakurigaku Zasshi 1995 : 105 : 295 303.
45. Kedici PS, Memikoglu MM, Kansu G, Isimer A, Gunhan O. Case report: ionisation tendency of a base metal alloy in the oral environment. Eur J Prosthodont Restor Dent 1995 : 3 : 231 234.
46. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr., Lott IT, et al. Retinoic acid embryopathy. N Engl J Med 1985 : 313 : 837 841.
47. Lind PO. Oral lichenoid reactions related to composite restorations. Preliminary report. Acta Odontol Scand 1988 : 46 : 63 65.
48. Lockhart PB. Gingival pigmentation as the sole presenting sign of chronic lead poisoning in a mentally retarded adult. Oral Surg Oral Med Oral Pathol 1981 : 52 : 143 149.
49. Lodi G, Scully C, Carrozzo M, Griffiths M, Surgerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 : 100 : 164 178.
50. Loughnan PM, Gold H, Vance JC. Phenytoin teratogenicity in man. Lancet 1973 : 1 : 70 72.
51. Lowe CR. Congenital malformations among infants born to epileptic women. Lancet 1973 : 1 : 9 10.
52. Lozada F, Silverman F Jr. Erythema multiforme. Clinical characteristics and natural history in fifty patients. Oral Surg Oral Med Oral Pathol 1978 : 46 : 628 636.
53. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004 : 117 : 440 441.
54. Lumbiganon P, Pengsaa K, Sookpranee T. Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatr Infect Dis J 1991 : 10 : 619 620.
55. Maguire A, Craft AW, Evans RG, Amineddine H, Kernahan J, Macleod RI, Murray JJ, Welbury RR. The long-term effects of treatment on the dental condition of children surviving malignant disease. Cancer 1987 : 60 : 2570 2575.
56. Maguire A, Murray JJ, Craft AW, Kernahan J, Welbury RR. Radiological features of the long-term effects from treatment of malignant disease in childhood. Br Dent J 1987 : 162 : 99 102.
57. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 : 61 : 1115 1117.
58. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005 : 63 : 1567 1575.
59. Mascarenhas AK, Allen CM, Moeschberger ML. The association between Viadent use and oral leukoplakia - results of a matched case-control study. J Public Health Den 2002 : 62 : 158 162.
60. McAllan LH, Adkins KF. Drug-induced palatal pigmentation. Aust Dent J 1986 : 31 : 1 4.
61. Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc 2005 : 136 : 1675 1681.
62. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005 : 136 : 1658 1668.
63. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005 : 104 : 83 93.
64. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005 : 90 : 1294 1301.
65. Pan VC, Quintela GA. Doxycycline-induced parotitis. Postgrad Med J 1991 : 67 : 313.
66. Perusse R, Morency R. Oral pigmentation induced by Premarin. Cutis 1991 : 48 : 61 64.
67. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 2003 : 67 : 968 970.
68. Praharaj SK, Verma P, Roy D, Singh A. Is clonidine useful for treatment of clozapine-induced sialorrhea? J Psychopharmacol 2005 : 19 : 426 428.
69. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In : Davies DM, editor. Textbook of adverse drug reactions. Oxford : Oxford University Press, 1985 : 44.
70. Rekola M. In vivo acid production from medicines in syrup form. Caries Res 1989 : 23 : 412 416.
71. Roberts IF, Roberts GJ. Relation between medicines sweetened with sucrose and dental disease. Br Med J 1979 : 2 : 14 16.
72. Robinson PG, Acquah S, Gibson B. Drug users: oral health-related attitudes and behaviours. Br Dent J 2005 : 198 : 219 224.
73. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 : 333 : 1600 1607.
74. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 : 62 : 527 534.
75. Safra MJ, Oakley GP Jr. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975 : 2 : 478 480.
76. Schaupp H, Wohnaut H. Disturbances of taste from oral disinfectants. HNO 1978 : 26 : 335 341.
77. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004 : 15 : 221 239.
78. Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000 2006 : 40 : 120 129.
79. Seymour RA, Thomason JM, Nolan A. Angiotensin converting enzyme (ACE) inhibitors and their implications for the dental surgeon. Br Dent J 1997 : 183 : 214 218.
80. Seymour RA, Thomason JM, Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med 1997 : 26 : 297 304.
81. Smart ER, Macleod RI, Lawrence CM. Resolution of lichen planus following removal of amalgam restorations in patients with proven allergy to mercury salts: a pilot study. Br Dent J 1995 : 178 : 108 112.
82. Solheim H, Eriksen HM, Nordbo H. Chemical plaque control and extrinsic discoloration of teeth. Acta Odontol Scand 1980 : 38 : 303 309.
83. Stead LR, Williams JV, Williams AC, Robinson CM. An investigation into the practice of tongue piercing in the South West of England. Br Dent J 2006 : 200 : 103 107.
84. Talner LB, Lang JH, Brasch RC, Lasser EC. Elevated salivary iodine and salivary gland enlargement due to iodinated contrast media. Am J Roentgenol Radium Ther Nucl Med 1971 : 112 : 380 382.
85. Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991 : 59 : 190 200.
86. Thomson WM, Slade GD, Spencer AJ. Dental caries experience and use of prescription medication amongst people age 60+ in South Australia. Gerodontology 1995 : 12 : 104 110.
87. Tuffanelli D, Abraham RK, Dubois EI. Pigmentation from antimalarial therapy. Its possible relationship to the ocular lesions. Arch Dermatol 1963 : 88 : 419 426.
88. Veraldi S, Schianchi-Veraldi R, Scarabelli G. Pigmentation of the gums following hydroxychloroquine therapy. Cutis 1992 : 49 : 281 282.
89. Vogel RI, Deasy MJ. Extrinsic discoloration of the oral mucosa. J Oral Med 1977 : 32 : 14 16.
90. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2004 : 61 : 1104 1107.
91. Watson IB, MacDonald DG. Amodioquine induced oral pigmentation - a light and electron microscopic study. J Oral Pathol 1974 : 3 : 16 21.
92. Webster WS, Ritchie HE. Teratogenic effects of alcohol and isotretinoin on craniofacial development: an analysis of animal models. J Craniofac Genet Dev Biol 1991 : 11 : 296 302.
93. Welbury R. Chemotherapy and childhood cancer: dental implications. Dent Update 1987 : 14 : 163.
94. Wolf R, Brenner S. An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? Dermatology 1994 : 189 : 1 4.
95. Zarychanski R, Elphee E, Walton P, Johnston J. Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol 2006 : 81 : 73 75.